Jean-Pierre Baylet, country head for India and cluster head for South Asia at Sanofi Pasteur, provides insights into the progress and room for improvement that lie ahead for India’s immunization program, while highlighting Sanofi’s unrivalled commitment to protecting the Indian population from vaccine- preventable diseases like polio and flu as well as his objectives and expectations regarding other critical diseases such as cholera, IPV, and dengue.
"In the public sector, the government is currently discussing the introduction of five new vaccines: rotavirus, novo conjugates for measles, rubella, and varicella as well as diphtheria & tetanus (DT) and HPV vaccines, while all of them are already approved in India and available through the Vaccine-Alliance Gavi."
